Anti-spike antibodies and neutralising antibody activity in people living with HIV vaccinated with COVID-19 mRNA-1273 vaccine: a prospective single-centre cohort study

BACKGROUND: Vaccines against COVID-19 are a powerful tool to control the current SARS-CoV-2 pandemic. A thorough description of their immunogenicity among people living with HIV (PLWHIV) is necessary. We aimed to assess the immunogenicity of the mRNA-1273 vaccine among PLWHIV. METHODS: In this prosp...

Descripción completa

Detalles Bibliográficos
Autores principales: Lombardi, Andrea, Butta, Giacomo M., Donnici, Lorena, Bozzi, Giorgio, Oggioni, Massimo, Bono, Patrizia, Matera, Malvina, Consonni, Dario, Ludovisi, Serena, Muscatello, Antonio, Ceriotti, Ferruccio, Conti, Matteo, Scaglioni, Susanna, Gallo, Greta, Scarpa, Edoardo, Letko, Michael, Abrignani, Sergio, Grifantini, Renata, De Francesco, Raffaele, Gori, Andrea, Manganaro, Lara, Bandera, Alessandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8694797/
https://www.ncbi.nlm.nih.gov/pubmed/34961855
http://dx.doi.org/10.1016/j.lanepe.2021.100287

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8694797/
https://www.ncbi.nlm.nih.gov/pubmed/34961855
http://dx.doi.org/10.1016/j.lanepe.2021.100287

Ejemplares similares